Biovac says its strategy is not limited to boosting production volumes, and includes extending its range of products
The Biovac Institute is in talks with the US International Development Finance Corporation and other potential financiers, as it seeks to raise R2bn to expand its vaccine manufacturing capacity. State-backed Biovac recently clinched a deal to bottle up to 100-million doses a year of Pfizer-BioNTech Covid-19 vaccines and helps manufacture smaller volumes of childhood vaccines for Pfizer and Sanofi.
The coronavirus pandemic has highlighted Africa’s dependence on vaccine imports and spurred a host of initiatives to ramp up manufacturing capacity on the continent, including support from international development finance institutions. Increasing vaccine manufacturing capacity on the continent would not only help combat the coronavirus pandemic, but also put Africa in a better position to navigate future health crises, said DFC COO David Marchick, who is visiting SA and India this week...
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Vaccine maker Biovac in search of R2bn in funding to lift outputBiovac says its strategy is not limited to boosting production volumes, and includes extending its range of products
Read more »
Vaccine maker Biovac in search of R2bn in funding to lift outputBiovac says its strategy is not limited to boosting production volumes, and includes extending its range of products
Read more »
Health Dept expecting busier vaccine sites as parents bring kids for COVID jabsAt this stage, children will only be allowed to get one shot of the Pfizer vaccine but this could change once further research determines whether a second dose is safe for this cohort.
Read more »
Sahpra did not approve the Sputnik V Covid-19 vaccine - the regulator highlighted a major concern | Health24The South African Health Products Regulatory Authority will not approve Russia's Sputnik V Covid-19 vaccine for use in South Africa until the developer can confirm that it doesn’t make people more vulnerable to HIV infection. | Health24com
Read more »
'We have enough vaccines,' says SAMA after Sputnik V rejection over HIV fearsSahpra on Monday announced its decision to reject the vaccine in its current form.
Read more »
What side effects can my child expect after getting the jab?The vaccine rollout for children between 12 and 17 years old will kick off from Wednesday.
Read more »